Related references
Note: Only part of the references are listed.Aggressive versus indolent insulinomas: new clinicopathological insights
Wenzel M. Hackeng et al.
ENDOCRINE-RELATED CANCER (2023)
Immunohistochemical somatostatin receptor expression in insulinomas
Elina Peltola et al.
APMIS (2023)
Development of an 111In-Labeled Glucagon-Like Peptide-1 Receptor-Targeting Exendin-4 Derivative that Exhibits Reduced Renal Uptake
Shimpei Iikuni et al.
MOLECULAR PHARMACEUTICS (2022)
Innovative imaging of insulinoma: the end of sampling? A review
Emanuel Christ et al.
ENDOCRINE-RELATED CANCER (2020)
Clinico–pathological features, treatments and survival of malignant insulinomas: a multicenter study
A Veltroni et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)
68Ga-Exendin-4 PET/CT Detects Insulinomas in Patients With Endogenous Hyperinsulinemic Hypoglycemia in MEN-1
Kwadwo Antwi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Glucagon-like peptide 1 (GLP-1)
T. D. Mueller et al.
MOLECULAR METABOLISM (2019)
Succinylated Gelatin Improves the Theranostic Potential of Radiolabeled Exendin-4 in Insulinoma Patients
Mijke Buitinga et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Characteristics and Outcomes of 79 Patients with an Insulinoma: A Nationwide Retrospective Study in Finland
Elina Peltola et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2018)
ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors
M. Falconi et al.
NEUROENDOCRINOLOGY (2016)
Glucagon-like-peptide-1 receptor expression in normal and diseased human thyroid and pancreas
Beatrice Waser et al.
MODERN PATHOLOGY (2015)
Expression of Glucagon-Like Peptide 1 Receptor and its Effects on Biologic Behavior in Pancreatic Neuroendocrine Tumors
Ana Ines Cases et al.
PANCREAS (2014)
A Systematic Review of Localization, Surgical Treatment Options, and Outcome of Insulinoma
Arianeb Mehrabi et al.
PANCREAS (2014)
Somatostatin Receptor Subtype 2A Immunohistochemistry Using a New Monoclonal Antibody Selects Tumors Suitable for In Vivo Somatostatin Receptor Targeting
Meike Koerner et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Functional Pancreatic Endocrine Tumor Syndromes
Robert T. Jensen et al.
NEUROENDOCRINOLOGY (2012)
Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline
Philip E. Cryer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting
JC Reubi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Share Paper
